eicosapentaenoic acid ethyl ester has been researched along with Cancer of Pancreas in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akita, H | 1 |
Takahashi, H | 1 |
Asukai, K | 1 |
Tomokuni, A | 1 |
Wada, H | 1 |
Marukawa, S | 1 |
Yamasaki, T | 1 |
Yanagimoto, Y | 1 |
Takahashi, Y | 1 |
Sugimura, K | 1 |
Yamamoto, K | 1 |
Nishimura, J | 1 |
Yasui, M | 1 |
Omori, T | 1 |
Miyata, H | 1 |
Ochi, A | 1 |
Kagawa, A | 1 |
Soh, Y | 1 |
Taniguchi, Y | 1 |
Ohue, M | 1 |
Yano, M | 1 |
Sakon, M | 1 |
1 trial available for eicosapentaenoic acid ethyl ester and Cancer of Pancreas
Article | Year |
---|---|
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study.
Topics: Aged; Chemoradiotherapy; Dietary Supplements; Eicosapentaenoic Acid; Female; Humans; Male; Middle Ag | 2019 |